TS-1単独、TS-1/CDDP併用療法に抵抗性の進行再発胃癌に対する二次治療の無作為化第II相試験(OGSG0701)
研究実績
検索結果:
すべて の研究実績
進行・再発大腸癌に対するCPT-11+S-1併用化学療法の第Ⅱ相試験(OGSG0405)
TS-1抵抗性の進行・再発胃癌に対するPaclitaxel/Doxifluridine療法の第II相臨床試験(OGSG0302)
Multicenter phase II study of irinotecan plus bolus fluoroutacil/l-leucovorin for metastasic colorectal cancer(OGSG0201)
Multicenter phase II study of 2 weeks administration with TS-1 followed by 1 week rest against metastatic gastric cancer
Phase I/II Study of CPT-11 plus UFT in Patients with Advanced/Recurrent Colorectal Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group(OGSG0102)
Muticenter Phase II Study of 2 Weeks Administration with TS-1 Followed by 1 Week Rest against Metastatic Gastric Cancer
Multi-center, phase II study for combination therapy with pacritaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1(OGSG0302)
胃癌治療に対する大阪消化管がん化学療法研究会(OGSG)の取り組みの現状と展望
進行再発胃癌に対するTXL+CPT-11併用療法の多施設共同第Ⅰ/Ⅱ相試験